Abramsonc Cancer Center of The University of Pennsylvania — Philadelphia, Pennsylvania

Abramsonc Cancer Center of The University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Abramsonc Cancer Center of The University of Pennsylvania has participated in 1 clinical trials.

Therapeutic areas: Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL.

Sponsors: University of Pennsylvania.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramsonc Cancer Center of The University of Pennsylvania?

Abramsonc Cancer Center of The University of Pennsylvania has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramsonc Cancer Center of The University of Pennsylvania conducted?

Abramsonc Cancer Center of The University of Pennsylvania has 1 clinical trials on record. Their work covers Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL.

Is Abramsonc Cancer Center of The University of Pennsylvania accredited by Crixeo Health?

Abramsonc Cancer Center of The University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramsonc Cancer Center of The University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.